• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Renin inhibition: what are the clinical perspectives?

作者信息

Hollenberg Norman K

机构信息

Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Semin Nephrol. 2007 Sep;27(5):511-8. doi: 10.1016/j.semnephrol.2007.07.006.

DOI:10.1016/j.semnephrol.2007.07.006
PMID:17868787
Abstract

Evidence that renin system blockade is useful in many patients with hypertension is overwhelming. Two recent lines of investigation have suggested that more complete blockade leads to improved clinical outcomes. One line of investigation involves the use of a combination of an angiotensin-converting enzyme inhibitor with an angiotensin-receptor blocker. The second line of investigation involves the use of very high dose angiotensin-receptor blocker. The interaction of renin with substrate is the rate-limiting step in the renin cascade; thus, the recent development of a powerful renin inhibitor also favors more complete blockade of the system. In many patients, this is likely to lead to improved treatment.

摘要

相似文献

1
Renin inhibition: what are the clinical perspectives?
Semin Nephrol. 2007 Sep;27(5):511-8. doi: 10.1016/j.semnephrol.2007.07.006.
2
The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?肾素系统:直接肾素抑制与AT1受体阻断或ACE环节阻断有何不同?
Rev Cardiovasc Med. 2007;8 Suppl 2:S7-13.
3
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?肾素-血管紧张素系统抑制对靶器官保护的作用:我们能否做得更好?
Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019.
4
Renin inhibition with aliskiren: where are we now, and where are we going?阿利吉仑对肾素的抑制作用:我们目前的状况如何,又将走向何方?
J Hypertens. 2006 Feb;24(2):243-56. doi: 10.1097/01.hjh.0000202812.72341.99.
5
Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.肾素-血管紧张素-醛固酮系统三联阻断对非糖尿病肾病的影响:在血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂联合治疗基础上加用醛固酮拮抗剂螺内酯
Hypertens Res. 2008 Jan;31(1):59-67. doi: 10.1291/hypres.31.59.
6
Renin inhibition--benefit beyond hypertension control.肾素抑制——高血压控制之外的益处。
J Assoc Physicians India. 2009 Jul;57:518-20, 525.
7
Inhibition of renin: an updated review of the development of renin inhibitors.肾素抑制:肾素抑制剂研发的最新综述
Curr Opin Investig Drugs. 2007 Sep;8(9):750-7.
8
Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.钙通道阻滞剂和肾素-血管紧张素系统阻滞剂对高血压血管疾病血管内及神经激素机制的影响。
Am J Hypertens. 2008 Oct;21(10):1076-85. doi: 10.1038/ajh.2008.258. Epub 2008 Aug 28.
9
Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.用于治疗高血压及相关疾病的新型肾素-血管紧张素-醛固酮系统阻断疗法。
J Hypertens. 2007 Jan;25(1):25-35. doi: 10.1097/HJH.0b013e3280113950.
10
Inhibiting the renin-angiotensin system: why and in which patients.抑制肾素-血管紧张素系统:原因及适用哪些患者。
J Am Acad Nurse Pract. 2009 Jan;21(1):66-75. doi: 10.1111/j.1745-7599.2008.00374.x.

引用本文的文献

1
Direct renin inhibition and the kidney.直接肾素抑制与肾脏。
Nat Rev Nephrol. 2010 Jan;6(1):49-55. doi: 10.1038/nrneph.2009.201. Epub 2009 Nov 24.
2
Renin inhibitors, clinical experience.
J Mol Med (Berl). 2008 Jun;86(6):691-5. doi: 10.1007/s00109-008-0338-y. Epub 2008 Apr 25.